- Merck Covid pill, Molnupiravir, has an effectiveness of 30% in preventing hospitalization or death for patients infected with Covid-19. It may however have a small chance of creating new Covid variants and could potenitally even change human DNA. https://www.sciencenews.org/article/covid-pill-merck-molnupiravir-antiviral-fda 13 comments science
Linking pages
- A new antiviral pill cuts COVID-19 hospitalization and death rates https://www.sciencenews.org/article/coronavirus-covid-antiviral-pill-merck-molnupiravir-hospitalization-death 460 comments
- Here’s the latest good and bad news about COVID-19 drugs https://www.sciencenews.org/article/covid-coronavirus-drugs-treatments-latest-news 0 comments
Linked pages
- The antidepressant fluvoxamine can reduce COVID-19 hospitalizations | Science News https://www.sciencenews.org/article/covid-antidepressant-fluvoxamine-drug-hospital-death 2244 comments
- A new antiviral pill cuts COVID-19 hospitalization and death rates https://www.sciencenews.org/article/coronavirus-covid-antiviral-pill-merck-molnupiravir-hospitalization-death 460 comments
- Why it’s still so hard to find treatments for early COVID-19 https://www.sciencenews.org/article/coronavirus-covid-19-why-early-treatment-drugs 0 comments
Related searches:
Search whole site: site:www.sciencenews.org
Search title: Merck’s COVID-19 pill may soon be here. How well will it work?
See how to search.